annual CFF:
$12.77M+$2.41M(+23.30%)Summary
- As of today (July 26, 2025), ABCL annual cash flow from financing activities is $12.77 million, with the most recent change of +$2.41 million (+23.30%) on December 31, 2024.
- During the last 3 years, ABCL annual CFF has risen by +$16.66 million (+428.59%).
- ABCL annual CFF is now -98.13% below its all-time high of $683.65 million, reached on December 31, 2020.
Performance
ABCL Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$5.97M+$1.83M(+44.13%)Summary
- As of today (July 26, 2025), ABCL quarterly cash flow from financing activities is $5.97 million, with the most recent change of +$1.83 million (+44.13%) on March 31, 2025.
- Over the past year, ABCL quarterly CFF has increased by +$3.14 million (+110.88%).
- ABCL quarterly CFF is now -99.02% below its all-time high of $609.94 million, reached on December 31, 2020.
Performance
ABCL quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$15.91M+$3.14M(+24.58%)Summary
- As of today (July 26, 2025), ABCL TTM cash flow from financing activities is $15.91 million, with the most recent change of +$3.14 million (+24.58%) on March 31, 2025.
- Over the past year, ABCL TTM CFF has increased by +$2.26 million (+16.58%).
- ABCL TTM CFF is now -97.67% below its all-time high of $683.65 million, reached on December 31, 2020.
Performance
ABCL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ABCL Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | +110.9% | +16.6% |
| 3 y3 years | +428.6% | +290.7% | +390.6% |
| 5 y5 years | +6448.2% | -93.2% | -81.9% |
ABCL Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +428.6% | -9.9% | +1403.5% | at high | +1077.2% |
| 5 y | 5-year | -98.1% | +428.6% | -99.0% | +141.5% | -97.7% | +390.6% |
| alltime | all time | -98.1% | +428.6% | -99.0% | +141.5% | -97.7% | +390.6% |
ABCL Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.97M(+44.1%) | $15.91M(+24.6%) |
| Dec 2024 | $12.77M(+23.3%) | $4.14M(+31.7%) | $12.77M(+3.0%) |
| Sep 2024 | - | $3.15M(+18.6%) | $12.39M(-21.9%) |
| Jun 2024 | - | $2.65M(-6.4%) | $15.88M(+16.4%) |
| Mar 2024 | - | $2.83M(-24.8%) | $13.64M(+31.8%) |
| Dec 2023 | $10.36M(-736.1%) | $3.77M(-43.2%) | $10.36M(+49.2%) |
| Sep 2023 | - | $6.63M(+1482.3%) | $6.94M(+2284.9%) |
| Jun 2023 | - | $419.00K(-191.5%) | $291.00K(-72.2%) |
| Mar 2023 | - | -$458.00K(-231.2%) | $1.04M(-164.2%) |
| Dec 2022 | -$1.63M | $349.00K(-1936.8%) | -$1.63M(+1038.5%) |
| Sep 2022 | - | -$19.00K(-101.6%) | -$143.00K(-118.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.17M(-137.5%) | $774.00K(-114.1%) |
| Mar 2022 | - | -$3.13M(-270.7%) | -$5.47M(+40.9%) |
| Dec 2021 | -$3.89M(-100.6%) | $1.83M(+104.2%) | -$3.89M(-100.6%) |
| Sep 2021 | - | $898.00K(-117.7%) | $604.22M(+2.6%) |
| Jun 2021 | - | -$5.08M(+228.9%) | $588.95M(-0.9%) |
| Mar 2021 | - | -$1.54M(-100.3%) | $594.37M(-13.1%) |
| Dec 2020 | $683.65M(>+9900.0%) | $609.94M(-4344.5%) | $683.65M(+827.4%) |
| Sep 2020 | - | -$14.37M(-4253.2%) | $73.71M(-16.3%) |
| Jun 2020 | - | $346.00K(-99.6%) | $88.08M(+0.4%) |
| Mar 2020 | - | $87.74M | $87.74M |
| Dec 2019 | $195.00K(-98.4%) | - | - |
| Dec 2018 | $12.19M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual CFF year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly CFF year-on-year change?
- What is AbCellera Biologics Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM CFF year-on-year change?
What is AbCellera Biologics Inc. annual cash flow from financing activities?
The current annual CFF of ABCL is $12.77M
What is the all time high annual CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash flow from financing activities is $683.65M
What is AbCellera Biologics Inc. annual CFF year-on-year change?
Over the past year, ABCL annual cash flow from financing activities has changed by +$2.41M (+23.30%)
What is AbCellera Biologics Inc. quarterly cash flow from financing activities?
The current quarterly CFF of ABCL is $5.97M
What is the all time high quarterly CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash flow from financing activities is $609.94M
What is AbCellera Biologics Inc. quarterly CFF year-on-year change?
Over the past year, ABCL quarterly cash flow from financing activities has changed by +$3.14M (+110.88%)
What is AbCellera Biologics Inc. TTM cash flow from financing activities?
The current TTM CFF of ABCL is $15.91M
What is the all time high TTM CFF for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash flow from financing activities is $683.65M
What is AbCellera Biologics Inc. TTM CFF year-on-year change?
Over the past year, ABCL TTM cash flow from financing activities has changed by +$2.26M (+16.58%)